# EDGAR Filing Document

**Accession Number:** 0001630176
**File Stem:** 0001096906-25-001557
**Filing Date:** 2025-9
**Character Count:** 5022
**Document Hash:** 2743c80817ce8b2943436865e73b3415
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096906-25-001557.hdr.sgml**: 20250923

**ACCESSION NUMBER**: 0001096906-25-001557

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250916

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20250923

**DATE AS OF CHANGE**: 20250923

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHY EXTRACTS INC.
- **CENTRAL INDEX KEY:** 0001630176
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 472594704
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55572
- **FILM NUMBER:** 251332378

**BUSINESS ADDRESS:**
- **STREET 1:** 7375 COMMERCIAL WAY
- **STREET 2:** SUITE 125
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89011
- **BUSINESS PHONE:** 702-505-0471

**MAIL ADDRESS:**
- **STREET 1:** 7375 COMMERCIAL WAY
- **STREET 2:** SUITE 125
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89011

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHLY EXTRACTS INC.
- **DATE OF NAME CHANGE:** 20210219

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GREY CLOAK TECH INC.
- **DATE OF NAME CHANGE:** 20150108

?xml version='1.0' encoding='ASCII'? HEALTHY EXTRACTS INC. - Form 8-K SEC filing

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

---

| | |
|:---|:---|
| Date of Report (Date of earliest event reported): | **September 16, 2025** |

---

**HEALTHY EXTRACTS INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada**<br> (State or other<br> jurisdiction of incorporation) | **000-55572**<br> (Commission<br> File Number) | **47-2594704**<br> (I.R.S. Employer<br> Identification No.) |
| **7375 Commercial Way, Suite 125**<br> **Henderson, NV 89011**<br> (Address of principal executive offices) (zip code) | **7375 Commercial Way, Suite 125**<br> **Henderson, NV 89011**<br> (Address of principal executive offices) (zip code) | **7375 Commercial Way, Suite 125**<br> **Henderson, NV 89011**<br> (Address of principal executive offices) (zip code) |
| **(702) 463-1004**<br> (Registrant's telephone number, including area code) | **(702) 463-1004**<br> (Registrant's telephone number, including area code) | **(702) 463-1004**<br> (Registrant's telephone number, including area code) |
| (Former name or former address, if changed since last report.) | (Former name or former address, if changed since last report.) | (Former name or former address, if changed since last report.) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

------

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

[_]

**Section 5 – Corporate Governance and Management**

**Item 5.02** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

Effective on September 16, 2025, Donald Swanson was appointed as our Chief Executive Officer, replacing Kevin "Duke" Pitts, who was appointed as our President (replacing Donald Swanson) and Chief Operating Officer.

There are no family relationships between any of our officers or directors.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **Healthy Extracts Inc.** |
| Dated: September 22, 2025 | /s/ Kevin "Duke" Pitts |
|  | By:Kevin "Duke" Pitts  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Its:President and Chief Operating Officer  |

---

------